CMG6A19
/ Chimagen Biosci, BioRay Biopharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 22, 2025
A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies
(clinicaltrials.gov)
- P1 | N=120 | Suspended | Sponsor: BioRay Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Suspended
Trial suspension • Oncology • Solid Tumor
April 29, 2024
A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies
(clinicaltrials.gov)
- P1 | N=120 | Not yet recruiting | Sponsor: BioRay Pharmaceutical Co., Ltd.
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1